Evidence map›Paper›PMID 39075067›Full record

ArticleNature communications2024

The small CRL4

Diana A Llerena Schiffmacher, Shun-Hsiao Lee, Katarzyna W Kliza, Arjan F Theil, Masaki Akita, Angela Helfricht, Karel Bezstarosti, Camila Gonzalo-Hansen, Haico van Attikum, Matty Verlaan-de Vries and 10 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Topology Resetting During Transcription-Coupled Nucleotide Excision Repair.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Diana A Llerena Schiffmacher *Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.ORCID 0009-0000-5938-9311
Shun-Hsiao Lee *Division of Biochemistry and Oncode institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.ORCID 0000-0002-6732-1947
Katarzyna W KlizaDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Oncode Institute, Radboud University Nijmegen, 6525 GA, Nijmegen, the Netherlands.ORCID 0000-0002-1213-1812
Arjan F TheilDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.ORCID 0000-0001-5779-1681
Masaki AkitaDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.
Angela HelfrichtDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.
Karel BezstarostiProteomics Center, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.
Camila Gonzalo-HansenDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Oncode Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.
Haico van AttikumDepartment of Human Genetics, Leiden University Medical Center, 2333 ZC, Leiden, The Netherlands.
Matty Verlaan-de VriesDepartment of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZC, Leiden, The Netherlands.
Alfred C O VertegaalDepartment of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZC, Leiden, The Netherlands.
Jan H J HoeijmakersDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.ORCID 0000-0003-3526-7795
Jurgen A MarteijnDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Oncode Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.ORCID 0000-0001-9321-518X
Hannes LansDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.ORCID 0000-0003-4417-5358
Jeroen A A DemmersProteomics Center, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands.ORCID 0000-0002-8757-9611
Michiel VermeulenDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Oncode Institute, Radboud University Nijmegen, 6525 GA, Nijmegen, the Netherlands.ORCID 0000-0003-0836-6894
Titia K SixmaDivision of Biochemistry and Oncode institute, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.ORCID 0000-0001-6180-0632
Tomoo OgiDepartment of Genetics, Research Institute of Environmental Medicine (RIeM), Nagoya University, Nagoya, Japan.ORCID 0000-0002-5492-9072
Wim VermeulenDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands. w.vermeulen@erasmusmc.nl.ORCID 0000-0003-3616-734X
Alex PinesDepartment of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD, Rotterdam, The Netherlands. a.pines@erasmusmc.nl.ORCID 0000-0001-7990-910X

Funding

THE IMPACT OF CELLULAR DEFENSE ON THE ROLE OF Ku80 IN GENOME MAINTENANCE AND LONGP01AG017242 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI VIJG, JAN · 1999 to 2023
$46.1M
Deutsche Forschungsgemeinschaft (German Research Foundation) 496650118European Molecular Biology Organization (EMBO) ALTF 1159-2019Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Netherlands Organisation for Scientific Research) 714.017.003NIA NIH HHS P01 AG017242ZonMw (Netherlands Organisation for Health Research and Development) 733050810
6 · The paper itself

Abstract

Transcription-blocking DNA lesions are specifically targeted by transcription-coupled nucleotide excision repair (TC-NER), which removes a broad spectrum of DNA lesions to preserve transcriptional output and thereby cellular homeostasis to counteract aging. TC-NER is initiated by the stalling of RNA polymerase II at DNA lesions, which triggers the assembly of the TC-NER-specific proteins CSA, CSB and UVSSA. CSA, a WD40-repeat containing protein, is the substrate receptor subunit of a cullin-RING ubiquitin ligase complex composed of DDB1, CUL4A/B and RBX1 (CRL4

Indexed as

DNA-Binding ProteinsExcision RepairUbiquitin-Protein LigasesCarrier ProteinsCryoelectron MicroscopyCullin ProteinsDNA DamageHEK293 CellsHumansProtein BindingReceptors, Interleukin-17Transcription, GeneticUbiquitinationCarrier ProteinsCullin ProteinsDDA1 protein, humanDNA-Binding ProteinsIL17RB protein, humanRBX1 protein, humanReceptors, Interleukin-17Ubiquitin-Protein Ligases

Identifiers

PMID39075067
PMCPMC11286758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.